PLA2G16 anticorps

N° du produit ABIN7254529

Détail du produit anti-PLA2G16 anticorps

Antigène: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G16 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Synthetic peptide of human PLA2G16

Isotype: IgG

Information d'application

Indications d'application: IHC 1:30-1:150, ELISA 1:5000-1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.1 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur PLA2G16

Antigène: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Autre désignation: PLA2G16 (PLA2G16 Produits)

Synonymes: anticorps HRASLS3, anticorps HREV107, anticorps HRSL3, anticorps AdPLA, anticorps H-REV107-1, anticorps HREV107-1, anticorps HREV107-3, anticorps C78643, anticorps Hrasls3, anticorps Hrev107, anticorps MLP-3, anticorps phospholipase A2 group XVI, anticorps phospholipase A2, group XVI, anticorps PLA2G16, anticorps Pla2g16

Sujet: Secretory phopholipase A2 (PLA2) enzymes cleave an acyl ester bond in the sn-2 position of glycerophospholipids. These extracellular proteins have a high disulfide bond content, low molecular mass (14 kDa), and require mM levels of Ca2+ for catalysis. They play a crucial role in the generation of arachidonates and eicosanoids, and have a number of biological actions including immunological responses, inflammation, cellular proliferation, vasoconstriction, and bronchioconstriction. Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.

UniProt: P53816

Pathways: Inositol Metabolic Process